Ani Pharmaceuticals (ANIP) Net Income Growth (3y) (2014 - 2026)
Powered by 
Analysis
Ani Pharmaceuticals (ANIP) Net Income Growth (3y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 14.04% |
| 2 | Viatris | 19.20 Bn | 18.31 Bn | 1.46 Bn | -34.81% |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.73 Bn | 396.53 Mn | -35.35% |
| 4 | Amneal Pharmaceuticals | 5.49 Bn | 5.36 Bn | 334.51 Mn | 32.86% |
| 5 | Bausch Health Companies | 2.31 Bn | 475.75 Mn | 2.10 Bn | 112.75% |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 58.10% |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 711.29 Mn | 93.47 Mn | 4.72% |
| 9 | Fennec Pharmaceuticals | 396.40 Mn | 355.15 Mn | 17.15 Mn | 33.27% |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 58.10% |
| Mar 31, 2026 | 171.48% |
| Dec 31, 2025 | 103.78% |
| Sep 30, 2025 | 72.05% |
| Jun 30, 2025 | 37.00% |
| Mar 31, 2025 | 40.61% |
| Dec 31, 2024 | 24.77% |
| Sep 30, 2024 | -76.04% |
| Jun 30, 2024 | 45.53% |
| Mar 31, 2024 | 449.05% |
| Dec 31, 2023 | 32.37% |
| Sep 30, 2023 | 177.66% |
| Jun 30, 2023 | 35.82% |
| Mar 31, 2023 | 30.27% |
| Dec 31, 2022 | 4.14% |
| Sep 30, 2022 | -61.15% |
| Jun 30, 2022 | -62.18% |
| Mar 31, 2022 | -260.28% |
| Dec 31, 2021 | -86.10% |
| Sep 30, 2021 | -42.27% |